The safest pharma sales rep jobs: Sales rep positions for drugmakers haven’t exactly been the surest bets for staying employed, but that’s not true for everyone in the profession. A new survey shows that pharmaceuticals firms expect to add jobs for reps who sell specialty drugs or serve hospitals. The survey offers reps lots of hope, suggesting that the “long, grim trend of sales force contraction may be coming to a close.”
FDA drug approval: Forest Labs and Switzerland’s Nycomed have managed to overcome some sharp criticism from a panel of experts and win a narrow approval of Daliresp to prevent the exacerbation of chronic obstructive pulmonary disease.
An existential threat to GPOs? Medtronic’s decision to drop group purchasing organization Novation is an “existential mega-threat” to the GPO industry’s business model.
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Venture capital conflict of interest? VCs trading shares of private companies on secondary markets in personal accounts “pose a potential minefield for firms raising new funds.”
On the bright side: People afflicted with chronic disease are “power users” when it comes to finding health information on the web and connecting with others online.
The placebo effect: This video examines “the strange powers” of the placebo effect.